Eptinezumab in Adults With Migraine and Medication Overuse Headache
Status:
Recruiting
Trial end date:
2022-09-12
Target enrollment:
Participant gender:
Summary
This study evaluates the efficacy of eptinezumab to prevent migraine and headache in patients
with the combined diagnosis of migraine and medication overuse headache